Stock Information
Arbutus Biopharma Corp (ABUS)
Ticker Symbol: ABUS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $861.61 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.1754
Revenue (TTM): $0.07 M
Dividend Yield: N/A%
ROE: -42.39%
Latest News
-
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Thu, Apr 16, 2026 8:03 AM
-
Why J B Hunt Transport Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Thu, Apr 16, 2026 5:28 AM
-
Arbutus Biopharma shares are trading higher after the FDA granted the company Fast Track designation for imdusiran for the treatment of chronic hepatitis B
Wed, Apr 15, 2026 9:15 AM
-
Arbutus Biopharma Gets FDA Fast-Track Designation for Imdusiran in Chronic Hepatitis B
Wed, Apr 15, 2026 8:21 AM
-
Arbutus Biopharma's Imdusiran Receives FDA's Fast Track Designation To Treat Chronic Hepatitis B
Wed, Apr 15, 2026 7:33 AM
-
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
Wed, Apr 15, 2026 7:30 AM
Key Financials
Financial data not available
